EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity

Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mi Na Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B virus, Virus Replication. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Antiviral therapy (AVT) is required in patients with newly diagnosed hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), if HBV DNA is detectable. We compared the risk of recurrence according to HBV replication activity at the curative treatment of HBV-related HCC.

Methods

Patients with HBV-related HCC who underwent surgical resection or radiofrequency ablation between 2013 and 2018 were enrolled in this retrospective cohort study. Patients were categorized into two groups according to HBV replication activity at the curative treatment of HBV-related HCC (group 1: patients who met the AVT indication for HBV-related HCC due to detectable HBV DNA but did not meet the AVT indication if without HCC; group 2: patients who met the AVT indication, regardless of HCC).

Results

In the entire cohort (n = 911), HCC recurred in 303 (33.3%) patients during a median follow-up of 4.7 years. After multivariate adjustment, group 2 showed a statistically similar risk of HCC recurrence (adjusted hazard ratio [aHR] = 1.18, P = 0.332) compared to that of group 1. In addition, group 2 showed statistically similar risks of early (< 2 years; aHR = 1.31) and late (≥ 2 years; aHR = 0.83) recurrence than that of group 1 (all P >0.05). Propensity score matching and inverse probability of treatment weighting analysis also yielded similar risks of HCC recurrence between the two groups (all P >0.05, log-rank tests).

Conclusions

The risk of HCC recurrence in patients who received curative treatment for newly diagnosed HBV-related HCC was similar regardless of HBV replication activity, if AVT was properly initiated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B virusVirus ReplicationNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedRetrospective StudiesDNA, ViralAgedAntiviral AgentsHepatitis B

Substanzen

DNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Seung Up Kim

Zitieren

APA

Kim, M. N., Kim, B. K., Cho, H., Goh, M. J., Roh, Y. H., Yu, S. J., Sinn, D. H., Park, S. Y., & Kim, S. U. (2024). Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity. PLOS ONE. https://doi.org/10.1371/journal.pone.0307712

Vancouver

Kim MN, Kim BK, Cho H, Goh MJ, Roh YH, Yu SJ, et al. Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity. PLOS ONE. 2024. doi:10.1371/journal.pone.0307712

BibTeX
@article{Kim2024,
  author = {Kim, Mi Na and Kim, Beom Kyung and Cho, Heejin and Goh, Myung Ji and Roh, Yun Ho and Yu, Su Jong and Sinn, Dong Hyun and Park, Soo Young and Kim, Seung Up},
  title = {Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307712}
}
Kostenlos starten →